Liraglutide reduces biomarkers and vascular risk in patients with diabetes mellitus type 2

Saved in:
Bibliographic Details
Published inRevista medíca de Chile Vol. 141; no. 12; pp. 1602 - 1604
Main Authors García de Lucas, María Dolores, Olalla, Julián, Sempere, Marco
Format Journal Article
LanguageSpanish
Published Chile 01.12.2013
Subjects
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers - metabolism
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - metabolism
Female
Glucagon-Like Peptide 1 - analogs & derivatives
Glucagon-Like Peptide 1 - therapeutic use
Humans
Hypoglycemic Agents - therapeutic use
Liraglutide
Male
Middle Aged
Risk Assessment
Young Adult
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0717-6163
DOI:10.4067/S0034-98872013001200017